<DOC>
	<DOCNO>NCT02573727</DOCNO>
	<brief_summary>Continous infusion adrenaline + albumin Continous infusion terlipressin + albumin Response assess every 48 hour ( ) Complete response : Decrease serum creatinine 133 lmol/L ( 1.5 mg/dL ) . ( ii ) Partial response : 50 % serum creatinine decrease baseline final value &gt; 133 lmol/L ( &gt; 1.5 mg/dL ) . ( iii ) No response : Serum creatinine decrease &lt; 50 % baseline Treatment extend reversal HRS ( decrease creatinine 1.5 mg/dL ) maximum 7 day rescue treatment follow . If intolerant terlipressin , exclude study rescue treatment give form noradrenaline octreotide midodrine .</brief_summary>
	<brief_title>To Compare Response Rate Noradrenaline vs. Terlipressin Hepatorenal Syndrome Patients With Acute Chronic Liver Failure</brief_title>
	<detailed_description />
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<mesh_term>Hepatorenal Syndrome</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<mesh_term>Terlipressin</mesh_term>
	<mesh_term>Lypressin</mesh_term>
	<criteria>1 . Patients acute chronic liver failure present hepatorenal syndrome 2 . Patients consent study protocol signing informed consent . 1 . Age le 18 year 2 . Decompensated cirrhotics 3 . Patients undergoing renal replacement therapy ( hemodialysis/renal transplantation ) . 4 . Post liver transplantation patient . 5 . History coronary artery disease , ischaemic cardiomyopathy , ventricular arrhythmia , peripheral vascular disease . 6 . Patients obstructive uropathy . 7 . Patient withdraw non complaint study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>